Canaccord Genuity Group Has Lowered Expectations for Ionis Pharmaceuticals (NASDAQ:IONS) Stock Price
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) had its price target cut by investment analysts at Canaccord Genuity Group from $95.00 to $85.00 in a report released on Tuesday, Benzinga reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s price target would suggest a potential upside of 46.32% from the […]
8 Sep 08:12 · The Cerbat Gem